West Newton, MA, United States of America

Julia L Greenstein

This inventor holds 15 USPTO granted patents and 3 published patent applications, primarily in Allergen Immunology. Top assignees: Immulogic Pharmaceutical Corporation, Merck Patent Gmbh, Immulogic, Inc.. Active years: 1996-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Julia L Greenstein. Retrieved from https://idiyas.com/inventor/julia-l-greenstein

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 15 

% Patents Active = 93.3

Average Co-Inventor Count = 7.2

ph-index = 7

Forward Citations = 183(Granted Patents)


Company Filing History:


Years Active: 1996-2009

Loading Chart...
Areas of Expertise:
Allergen
T Cell Epitopes
Hapten-Carrier Conjugates
Feline Protein
Dermatophagoides
Drug-Abuse Therapy
Recombinant Peptides
Peptide Technology
Human T Cells
Immunotherapy
House Dust
Therapeutic Applications
15 patents (USPTO):Explore Patents

Title: Julia L Greenstein: Innovator in Allergy Research

Introduction

Julia L Greenstein is a prominent inventor based in West Newton, MA (US). She has made significant contributions to the field of allergy research, holding a total of 15 patents. Her work focuses on the development of therapeutic solutions for individuals suffering from allergies, particularly those related to house dust and feline proteins.

Latest Patents

Among her latest patents is the invention of a human T cell reactive feline protein (TRFP) isolated from house dust. This invention involves a substantially pure, covalently linked TRFP that has been isolated from vacuum bag extracts obtained through affinity purification of house dust collected from homes with cats. The patent also covers DNA encoding the TRFP, compositions containing the protein or peptide, and antibodies reactive with the TRFP. Additionally, she has developed methods for using recombinant TRFP or peptide, modified or mutated TRFP peptides, and their applications for diagnostic or therapeutic purposes. Another notable patent addresses T cell epitopes of major allergens from dermatophagoides, providing isolated peptides that include T cell epitopes of specific protein allergens. This invention aims to offer modified peptides with enhanced therapeutic properties while reducing side effects.

Career Highlights

Julia has worked with several notable companies in the pharmaceutical and biotechnology sectors. She has been associated with Immunologic Pharmaceutical Corporation and Merck Patent GmbH, where she contributed her expertise in allergy research and therapeutic development.

Collaborations

Throughout her career, Julia has collaborated with esteemed colleagues, including Richard D Garman and Malcolm L Gefter. These collaborations have further advanced her research and innovations in the field.

Conclusion

Julia L Greenstein is a trailblazer in allergy research, with a strong portfolio of patents that reflect her dedication to improving the lives of individuals with allergies. Her innovative work continues to pave the way for new therapeutic approaches in this important area of health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…